George Hammons
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: U.S. National Science Foundation (2006); United States Food and Drug Administration (1985–2023); Los Alamos National Laboratory (1972); East Carolina University (2014); Jefferson Community and Technical College (2014); Texas A&M University (2026)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
George Hammons' research focuses on the genotoxicity and epigenetic effects of nanomaterials, particularly titanium dioxide nanoparticles, in human cells. His work investigates how exposure to these substances can alter DNA methylation and microRNA expression. Hammons has also explored the anti-cancer effects of vorinostat on pancreatic cancer cells and has investigated gene expression profiles in pancreatic tumors from African American patients.
His research network includes several collaborators from the National Center for Toxicological Research, including Beverly Lyn‐Cook, Beverly Word, Marta Pogribna, and Fatemeh Nouri Emamzaden, with whom he has co-authored multiple publications. Hammons' work contributes to the understanding of potential health impacts associated with nanomaterial exposure and advancements in cancer research.
Hammons has published 74 papers, accumulating over 2,034 citations and an h-index of 24, indicating a significant body of scholarly work in his research areas.
Metrics
- h-index: 24
- Publications: 74
- Citations: 2,043
Selected Publications
-
Exposure to a Titanium Dioxide Product Alters MicroRNA Expression in Human Cells (2026)
-
Exposure to a Titanium Dioxide Product Alters DNA Methylation in Human Cells (2024)
-
Abstract 4253: High expression of specific gene profiles in organoids from African American pancreatic cancer tumors (2024)
-
Epigenotoxicity of Titanium Dioxide Nanoparticles (2023)
-
Abstract 6251: High expression level of GSK3β in basal triple negative breast cancer: Effects of the HDAC inhibitor, vorinostat (2023)
-
Effect of titanium dioxide nanoparticles on histone modifications and histone modifying enzymes expression in human cell lines (2022)
-
Abstract 1631: Anti-cancer effects of vorinostat on 3D cultured pancreatic cancer cells (2022)
-
Abstract 995: Alpelisib and vorinostat modulate critical genes in basal-2 triple negative breast cancer cells and inhibit cell growth and invasion (2021)
-
Epigenetic Effects of Nanomaterials and Nanoparticles (2021)
-
Abstract B125: Molecular profiling basal 2 subtypes of triple-negative breast cancer cells and their response to histone deacetylase inhibitor (2020)
-
Abstract PO-218: Molecular profiling of basal 2 subtypes of triple negative breast cancer cells and their response to a histone deacetylase inhibitor (2020)
-
Effect of titanium dioxide nanoparticles on DNA methylation in multiple human cell lines (2020)
-
Proteomics Profiling of Pancreatic Cancer and Pancreatitis for Biomarkers Discovery (2018)
-
Abstract B19: The role of ABCB1 genotypes and targeting cancer stem cells in pancreatic cancer: Effects of metformin and dietary agents (2017)
-
In vitro analysis of factors influencing<i>CYP1A2</i>expression as potential determinants of interindividual variation (2017)
Collaboration Network
Top Collaborators
- Effect of titanium dioxide nanoparticles on histone modifications and histone modifying enzymes expression in human cell lines
- Epigenotoxicity of Titanium Dioxide Nanoparticles
- Exposure to a Titanium Dioxide Product Alters DNA Methylation in Human Cells
- Abstract 1631: Anti-cancer effects of vorinostat on 3D cultured pancreatic cancer cells
- Abstract 995: Alpelisib and vorinostat modulate critical genes in basal-2 triple negative breast cancer cells and inhibit cell growth and invasion
Showing 5 of 6 shared publications
- Effect of titanium dioxide nanoparticles on histone modifications and histone modifying enzymes expression in human cell lines
- Exposure to a Titanium Dioxide Product Alters DNA Methylation in Human Cells
- Abstract 1631: Anti-cancer effects of vorinostat on 3D cultured pancreatic cancer cells
- Abstract 995: Alpelisib and vorinostat modulate critical genes in basal-2 triple negative breast cancer cells and inhibit cell growth and invasion
- Abstract 6251: High expression level of GSK3β in basal triple negative breast cancer: Effects of the HDAC inhibitor, vorinostat
Showing 5 of 6 shared publications
- Epigenetic Effects of Nanomaterials and Nanoparticles
- Effect of titanium dioxide nanoparticles on histone modifications and histone modifying enzymes expression in human cell lines
- Epigenotoxicity of Titanium Dioxide Nanoparticles
- Exposure to a Titanium Dioxide Product Alters DNA Methylation in Human Cells
- Exposure to a Titanium Dioxide Product Alters MicroRNA Expression in Human Cells
- Epigenotoxicity of Titanium Dioxide Nanoparticles
- Exposure to a Titanium Dioxide Product Alters DNA Methylation in Human Cells
- Exposure to a Titanium Dioxide Product Alters MicroRNA Expression in Human Cells
- Abstract 1631: Anti-cancer effects of vorinostat on 3D cultured pancreatic cancer cells
- Abstract 6251: High expression level of GSK3β in basal triple negative breast cancer: Effects of the HDAC inhibitor, vorinostat
- Abstract 995: Alpelisib and vorinostat modulate critical genes in basal-2 triple negative breast cancer cells and inhibit cell growth and invasion
- Exposure to a Titanium Dioxide Product Alters DNA Methylation in Human Cells
- Exposure to a Titanium Dioxide Product Alters DNA Methylation in Human Cells
- Exposure to a Titanium Dioxide Product Alters DNA Methylation in Human Cells
- Exposure to a Titanium Dioxide Product Alters MicroRNA Expression in Human Cells
- Exposure to a Titanium Dioxide Product Alters MicroRNA Expression in Human Cells
- Exposure to a Titanium Dioxide Product Alters MicroRNA Expression in Human Cells
Similar Researchers
Based on overlapping research topics